CDR-Life is a biopharmaceutical company redefining antibody therapies to transform the lives of people with sight- and life-threatening diseases. The foundation is a modular antibody fragment platform for composing antibodies with ideal pharmacological and drug-like properties.

Products, services, technology

CDR-Life’s lead programs include trispecific immunotherapies that are highly tumor-selective for increased efficacy and reduced toxicity. The company’s portfolio contains several first-in-class immunotherapies against hematological as well as solid tumor malignancies.

Cooperation possibilities

CDR-Life partners with leading pharmaceutical companies that share our vision of bringing our highly innovative antibody therapies to patients.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2017
  • Number of employees in Switzerland
    10-19
Key business